Definitive Contract HHSN261201200033C

<p>This is a $150,000 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Bioptix Diagnostics, Inc., a for-profit manufacturer. The contract is for Phase I of a Small Business Innovation Research (SBIR) project under Topic 281. The contract has a completion date of June 29, 2011. As an SBIR award, this contract was set aside for small businesses.</p>

The U.S. National Cancer Institute awarded a $1,499,984.00 Small Business Innovation Research (SBIR) Phase II contract to Intelligent Optical Systems, Inc., a manufacturer of optical sensing and instrumentation technologies based in Torrance, California. The contract is for the development of a biopsy optical sensor for in situ tissue analysis under Topic 331. This is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the work is expected to be completed by September 18, 2021....

<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>

This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Akrotome Imaging, Inc. The $249,912 Firm-Fixed-Price contract supports the development of novel imaging agents to expand the clinical toolkit for cancer diagnosis, staging, and surgical guidance. The contract is focused on creating a fluorescence imaging probe that can be topically applied in the surgical cavity following...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Radiopharmaceutical Imaging And Dosimetry, LLC (doing business as Radiopharmaceutical Imaging &amp; Dosimetry LLC), a for-profit limited liability company. The $299,466.00 firm-fixed-price contract, which was set aside for small businesses, is for the development of user-friendly, platform-independent software to incorporate...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Diagnologix, LLC, a self-certified small disadvantaged business, for the development of &quot;SBIR 360: A SIMPLE END-TO-END SYSTEM FOR SERIAL CELL SORTING AND MANIPULATION USING A SINGLE CONTAINER.&quot; The firm-fixed-price contract, with a potential value of $350,000.00, has a completion date of August 31, 2018. This SBIR...

This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&amp;D. The contract has a period of performance through January 2024 and is...

This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Radiopharmaceutical Imaging and Dosimetry, LLC, doing business as Radiopharmaceutical Imaging &amp; Dosimetry LLC, a small business. The contract, valued at $299,275, is for a Small Business Innovation Research (SBIR) Phase I project to optimize targeted radionuclide therapy for metastatic liver cancer patients. This contract supports the NCI's broader...

<p>The National Cancer Institute (NCI) awarded a $249,792 Small Business Innovation Research (SBIR) Phase I contract to Biotex, Inc. to develop &quot;Instruments and Devices that Preserve Molecular Profiles in Tumors&quot; under SBIR Topic 257. The contract is a firm-fixed-price definitive contract with a period of performance ending on June 30, 2010. This SBIR contract supports the NCI's research objectives related to advancing cancer diagnostics and therapeutics.</p>

This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of &quot;Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning&quot; as described in the original solicitation. This Phase I SBIR contract has a period of performance from...